Aatru's Market Focus

Negative Pressure Dressings: surgical incisions and chronic wounds

image1

Aatru has developed and patented a unique and innovative negative pressure dressing.  Upon FDA clearance,  this refined design will be intended to serve the surgical incision market and the traditional NPWT market for chronic wounds.   FDA submission is schedule for mid Q2, 2019 - 510K Class II clearance.

Aatru's Innovations

Aatru's Platform Technology

image2

Upon FDA approval, Aatru's patented technology is meant to deliver negative pressure solutions in dressings for multiple markets, from surgical sites to chronic wounds, to smart patch technology for cosmetic and dermal use.    Future dressing designs include sensor technology and other therapies such as heat, light, electro-stimulation, etc.  

The IP Portfolio

image3

Aatru Medical has built an extensive patent portfolio with 21 patent filings to date, a combination of  granted and patent-pending.   Aatru has filed Provisional, USPTO, and PCT to globally cover a wide range of designs, features, and embodiments.

Industry-disruptive Design and Cost

image4

Unlike the current industry-standard NPWT solutions in the market, the Aatru dressing, upon FDA approval, is intended to provide the patient with an exceptional wound dressing coupled with negative pressure in the  therapeutic range without the need, discomfort, or the high cost of a mechanical pump.

File Download

World Union of Wound Healing Societies - Closed Surgical Incision Management - Understanding the Role of NPWT - 2017


Aatru Medical NPWT for Surgical Incision video introduction - (note: pre-FDA product)

Let's start a conversation...

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aatru Medical, LLC

1301 East 9th Street, 27th Floor Cleveland, Ohio 44114

(216) 303-6063